Search Within

Nitya Prabhakar Raj

  1. "2018"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (4)
Groups
  1. Department of Medicine (16)
  2. Gastrointestinal Oncology Service (16)
  3. Solid Tumor Oncology Division (16)
  4. Weinberg Fellows (16)
  5. Center for Pancreatic Cancer Research (13)
  6. Radiology, Department of (6)

More Groups

People
  1. Diane Reidy (11)
  2. Brian Untch (4)
  3. David Klimstra (4)
  4. Virginia Kelly (4)
  5. Janet Li (3)
  6. Maeve Lowery (3)

More People

Years
  1. 2018 (16)
Publications
  1. Journal of Clinical Oncology (5)
  2. Pancreas (4)
  3. Annals of Oncology (2)
  4. American Society of Clinical Oncology Educational Book (1)
  5. Cancer Research (1)
  6. JCO Precision Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (7)
  2. Lippincott Williams & Wilkins (4)
  3. Oxford University Press (2)
  4. American Association for Cancer Research (1)
  5. Elsevier Science, Inc. (1)
  6. Nature Research (1)

Results (16)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pembrolizumab-based therapy in previously treated high grade extrapulmonary neuroendocrine carcinomas
    Meeting Abstract

    Hooker, C.; Chan, J. A.; Aggarwal, R. R.; Cinar, P.; Hope, T.; Kolli, K.; Zhang, L.; Calabrese, S.; Grabowsky, J. A.; Zhang, J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • High frequency mismatch repair (MMR) pathway mutations in adrenocortical carcinoma: Indication for routine MMR-deficiency (MMR-D) testing
    Meeting Abstract

    Akala, O. O.; Kelly, V.; Strong, V. E.; Gopalan, A.; Reidy, D. L.; Raj, N. P.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Pilot study of gemcitabine, nab-paclitaxel, PEGPH20, and rivaroxaban for advanced pancreatic adenocarcinoma: An interim analysis
    Meeting Abstract

    Yu, K. H.; Mantha, S.; Tjan, C.; Kaufmann, E. S.; Brenner, R.; Lowery, M. A.; Ku, G. Y.; Raj, N. P.; Shcherba, M.; Goldberg, Z.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Widespread somatic loss of heterozygosity as a possible marker of disease aggressiveness in metastatic well differentiated pancreatic neuroendocrine tumors
    Meeting Abstract

    Akala, O. O.; Shah, R.; Untch, B. R.; Kelly, V.; Chou, J. F.; Ladanyi, M.; Berger, M. F.; Klimstra, D. S.; Reidy, D. L.; Raj, N. P.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Somatostatin receptor-based imaging and treatment of murine pancreatic neuroendocrine tumors induced by MEN1-loss
    Meeting Abstract

    Li, J. W.; Zhang, H.; Carlin, S. D.; Raj, N.; Klimstra, D. S.; Libutti, S. K.; Weber, W. A.; Reidy-Lagunes, D.; Untch, B. R.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Real-time genomic characterization of metastatic pancreatic neuroendocrine tumors has prognostic implications and identifies potential germline actionability
    Journal Article

    Raj, N.; Shah, R.; Stadler, Z.; Mukherjee, S.; Chou, J.; Untch, B.; Li, J.; Kelly, V.; Osoba, M.; Saltz, L. B.; more...
    JCO Precision Oncology (2018)

    Fulltext@MSK | Save
  • A pilot study of gemcitabine, nab-paclitaxel, PEGPH20 (PAG) and rivaroxaban for advanced pancreatic adenocarcinoma: Interim safety and efficacy analysis
    Meeting Abstract

    Yu, K.; Mantha, S.; Tjan, C.; Kaufmann, E.; Brenner, R. B.; Lowery, M.; Ku, G.; Raj, N.; Shcherba, M.; Goldberg, Z.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Activity & safety of spartalizumab (PDR001) in patients (pts) with advanced neuroendocrine tumors (NET) of pancreatic (Pan), gastrointestinal (GI), or thoracic (T) origin, & gastroenteropancreatic neuroendocrine carcinoma (GEP NEC) who have progressed on prior treatment (Tx)
    Meeting Abstract

    Yao, J. C.; Strosberg, J.; Fazio, N.; Pavel, M. E.; Ruszniewski, P.; Bergsland, E.; Li, D.; Tafuto, S.; Raj, N.; Campana, D.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • A phase II trial of LEE011 in combination with everolimus in the treatment of advanced well differentiated neuroendocrine tumors of foregut origin
    Meeting Abstract

    Raj, N. P.; Kelly, V.; Chan, J. A.; Dasari, A.; Capanu, M.; Tang, L.; Reidy, D. L.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Biology and systemic treatment of advanced gastroenteropancreatic neuroendocrine tumors
    Journal Article

    Raj, N.; Fazio, N.; Strosberg, J.
    American Society of Clinical Oncology Educational Book (2018)

    Fulltext@MSK | Save